Bangladesh doctors urge Viagra production halt

Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the counter.

The government's Drug Control Committee recently granted licences to more than a dozen companies to make and market sildenafil citrate—better known as Viagra—in two forms, overturning a decade-long policy.

But the Bangladesh Medical Association, which represents the nation's 32,000 doctors, protested the decision, worried that the drug would effectively become available over the counter to people for whom it could carry .

"We want the government to cancel the licences because the drug, if it isn't prescribed by specialists, can seriously undermine ," its general secretary Sharfuddin Ahmed said.

The association will hold an emergency meeting to discuss the decision next week, Ahmed said, citing fears over a lack of regulation on drug sales.

"Anyone can buy any type of medicine over-the-counter at pharmacies here, even the drugs that are strictly meant to be prescribed by specialist physicians," he said.

The decision to grant licences came after a technical body argued that the number of people suffering from erectile dysfunction was increasing in the country, according to minutes of the committee meeting posted in its website.

At the moment, Viagra is not legally available for anyone in Bangladesh, even with a prescription.

"We have this month allowed some 13 to produce sildenafil citrate," Shah Ruhul Amin, an official of the government's drug administration, told AFP.

"Previously some firms were allowed to produce the drug only for export. But this time we've allowed it for the Bangladeshi market as experts opined in favour of its approval," he said.

Doctors have said misuse of sildenafil can lead to , , strike and diabetes.

add to favorites email to friend print save as pdf

Related Stories

S. Korea to approve Viagra generics

Mar 14, 2012

Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Thailand to sell generic Viagra drug: officials

Sep 26, 2012

Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

EU approves kids' use of Pfizer lung medicine

May 05, 2011

(AP) -- Drugmaker Pfizer Inc. said Thursday that the European commission has approved treating children with its medicine for a rare, deadly lung condition - a drug better known as Viagra.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments